Laboratory Testing for Diagnosis of Severe Persistent Asthma
Spirometry with bronchodilator reversibility testing is the essential laboratory test for diagnosing severe persistent asthma, showing airflow obstruction with FEV1 <60% of predicted value and reduced FEV1/FVC ratio. 1
Core Diagnostic Tests
1. Spirometry
- Required parameters:
2. Peak Expiratory Flow (PEF) Measurements
- Diurnal variation >20% over 1-2 weeks 1
- Values typically <60% of personal best in severe persistent asthma 1
- Less reliable than spirometry but useful for monitoring 1
3. Bronchial Challenge Testing
- Indicated when spirometry is normal but clinical suspicion remains high 1, 2
- Options include:
- Methacholine challenge
- Histamine challenge
- Exercise challenge
- Cold air challenge
- Positive test confirms airway hyperresponsiveness 1
Biomarkers of Inflammation
1. Fractional Exhaled Nitric Oxide (FeNO)
- Elevated in eosinophilic airway inflammation 1
- Useful for:
- Supporting diagnosis in atopic asthma
- Monitoring response to corticosteroid therapy
- Assessing medication adherence 1
2. Sputum Analysis
- Eosinophil count in induced sputum
- Elevated in eosinophilic asthma phenotype 1
- Helps guide therapy, particularly for severe asthma 1
Additional Testing for Severe Asthma Phenotyping
1. Blood Tests
- Complete blood count with differential (looking for eosinophilia)
- Total IgE levels
- Allergen-specific IgE
- These tests help identify atopic phenotype and eligibility for biologic therapies 1
2. Additional Pulmonary Function Tests
- Lung volumes measurement (to rule out restrictive defects)
- Diffusing capacity (to differentiate from COPD) 1, 3
- Inspiratory flow-volume loops (to evaluate for vocal cord dysfunction) 1
Imaging Studies
- Chest X-ray: To exclude alternative diagnoses 1
- Consider CT scan of chest and sinuses in severe cases to identify complications or comorbidities 1
Diagnostic Algorithm
Initial assessment: Document symptoms consistent with severe persistent asthma (symptoms throughout the day, frequent nighttime awakenings, extreme activity limitation, need for rescue medication several times daily) 1
Confirm diagnosis with spirometry: FEV1 <60% predicted, reduced FEV1/FVC ratio, and positive bronchodilator reversibility 1
Document exacerbation history: ≥2 exacerbations requiring oral corticosteroids in the past year supports classification as severe persistent asthma 1
Phenotype the asthma: Use biomarkers (FeNO, blood eosinophils, IgE) to determine inflammatory pattern 1
Rule out alternative diagnoses: Use additional testing as needed to exclude conditions that mimic severe asthma 1
Common Pitfalls to Avoid
Relying solely on symptoms: Patients often underestimate symptom severity; objective measures are essential 1
Missing comorbidities: Conditions like GERD, vocal cord dysfunction, and allergic bronchopulmonary aspergillosis can mimic or worsen asthma 1
Inadequate reversibility testing: A single normal spirometry does not rule out asthma; repeated testing or bronchoprovocation may be necessary 2
Overreliance on peak flow: While useful for monitoring, PEF is less reliable than spirometry for diagnosis 1, 4
Failure to assess small airway function: FEF25% and FEF75% may be more sensitive than FEV1 for detecting mild asthma 5
By following this comprehensive approach to laboratory testing, clinicians can accurately diagnose severe persistent asthma, determine the appropriate phenotype, and guide targeted therapy to reduce morbidity and mortality.